Equities

Jilin Province Huinan Changlong Bio-pharmacy Co Ltd

  • Add to watchlist
  • Add to portfolio
  • Add an alert

Jilin Province Huinan Changlong Bio-pharmacy Co Ltd

Actions
Health CarePharmaceuticals and Biotechnology
  • Price (HKD)2.02
  • Today's Change0.00 / 0.00%
  • Shares traded64.00k
  • 1 Year change+20.24%
  • Beta0.0893
Data delayed at least 15 minutes, as of Feb 13 2026 06:11 GMT.
More ▼
Notice
Important Notice
Please note that effective 5th February, 2026 the Financial Times will no longer publish or present securities from the Nairobi Stock Exchange.

Financials data is unavailable for this security.

Balance sheet Back to Overview

In millions of CNY
(except for per share items)
Fiscal data as of Dec 31 2024202420232022
ASSETS
Cash And Short Term Investments5396561,032
Total Receivables, Net455440585
Total Inventory60103133
Prepaid expenses------
Other current assets, total452.4718
Total current assets1,0991,2011,767
Property, plant & equipment, net313330360
Goodwill, net6.256.256.25
Intangibles, net0.020.020.03
Long term investments1,078753211
Note receivable - long term------
Other long term assets------
Total assets2,5312,3192,373
LIABILITIES
Accounts payable647166
Accrued expenses367300295
Notes payable/short-term debt0.400.400.40
Current portion long-term debt/capital leases728.00--
Other current liabilities, total358346353
Total current liabilities861725715
Total long term debt3.93751.96
Total debt76832.36
Deferred income tax1.942.743.02
Minority interest------
Other liabilities, total353641
Total liabilities901838761
SHAREHOLDERS EQUITY
Common stock565656
Additional paid-in capital515151
Retained earnings (accumulated deficit)1,5221,3731,505
Treasury stock - common------
Unrealized gain (loss)------
Other equity, total------
Total equity1,6301,4801,612
Total liabilities & shareholders' equity2,5312,3192,373
Total common shares outstanding560560560
Treasury shares - common primary issue000
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.